Safety and potential effectiveness of daunorubicin-containing liposomes in patients with advanced recurrent malignant CNS tumors

Cancer Chemother Pharmacol. 1999;43(2):178-9. doi: 10.1007/s002800050881.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Antibiotics, Antineoplastic / administration & dosage*
  • Antibiotics, Antineoplastic / adverse effects
  • Brain Neoplasms / drug therapy*
  • Daunorubicin / administration & dosage*
  • Daunorubicin / adverse effects
  • Drug Administration Schedule
  • Humans
  • Liposomes
  • Neoplasm Recurrence, Local / drug therapy*
  • Pilot Projects

Substances

  • Antibiotics, Antineoplastic
  • Liposomes
  • Daunorubicin